Works by Mahlangu, Johnny
Results: 62
Diagnosis and treatment challenges in lower resource countries: State‐of‐the‐art.
- Published in:
- Haemophilia, 2024, v. 30, p. 78, doi. 10.1111/hae.14956
- By:
- Publication type:
- Article
Eptacog beta for the management of patients with haemophilia A and B with inhibitors: A European perspective.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 257, doi. 10.1111/hae.14944
- By:
- Publication type:
- Article
World federation of hemophilia international hemophilia training fellowship program: 50 years of enhancing global care.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. S129, doi. 10.1111/hae.14617
- By:
- Publication type:
- Article
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors.
- Published in:
- Haemophilia, 2022, v. 28, n. 4, p. 548, doi. 10.1111/hae.14563
- By:
- Publication type:
- Article
Emicizumab state‐of‐the‐art update.
- Published in:
- Haemophilia, 2022, v. 28, p. 103, doi. 10.1111/hae.14524
- By:
- Publication type:
- Article
Haemophilia gene therapy—Update on new country initiatives.
- Published in:
- Haemophilia, 2022, v. 28, p. 61, doi. 10.1111/hae.14512
- By:
- Publication type:
- Article
Emicizumab state‐of‐the‐art update.
- Published in:
- Haemophilia, 2022, v. 28, p. 103, doi. 10.1111/hae.14524
- By:
- Publication type:
- Article
Haemophilia gene therapy—Update on new country initiatives.
- Published in:
- Haemophilia, 2022, v. 28, p. 61, doi. 10.1111/hae.14512
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. i, doi. 10.1111/hae.14463
- By:
- Publication type:
- Article
Patient preference for emicizumab versus prior factor therapy in people with haemophilia A: Results from the HAVEN 3 and HAVEN 4 studies.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e772, doi. 10.1111/hae.14421
- By:
- Publication type:
- Article
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 911, doi. 10.1111/hae.14418
- By:
- Publication type:
- Article
The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 921, doi. 10.1111/hae.14419
- By:
- Publication type:
- Article
The effect of emicizumab prophylaxis on long‐term, self‐reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 854, doi. 10.1111/hae.14363
- By:
- Publication type:
- Article
Efficacy and safety of subcutaneous prophylaxis with dalcinonacog alfa in adults with haemophilia B.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. 574, doi. 10.1111/hae.14315
- By:
- Publication type:
- Article
Health‐related quality of life and health status in adolescent and adult people with haemophilia A without factor VIII inhibitors—A non‐interventional study.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 398, doi. 10.1111/hae.14270
- By:
- Publication type:
- Article
Development and testing of the Satisfaction Questionnaire with Intravenous or Subcutaneous Hemophilia Injection and results from the Phase 3 HAVEN 3 study of emicizumab prophylaxis in persons with haemophilia A without FVIII inhibitors.
- Published in:
- Haemophilia, 2021, v. 27, n. 2, p. 221, doi. 10.1111/hae.14222
- By:
- Publication type:
- Article
Redefining prophylaxis in the modern era.
- Published in:
- Haemophilia, 2021, v. 27, p. 21, doi. 10.1111/hae.14035
- By:
- Publication type:
- Article
Health‐related quality of life and caregiver burden of emicizumab in children with haemophilia A and factor VIII inhibitors—Results from the HAVEN 2 study.
- Published in:
- Haemophilia, 2020, v. 26, n. 6, p. 1009, doi. 10.1111/hae.14183
- By:
- Publication type:
- Article
Long‐term safety and sustained efficacy for up to 5 years of treatment with recombinant factor IX Fc fusion protein in subjects with haemophilia B: Results from the B‐YOND extension study.
- Published in:
- Haemophilia, 2020, v. 26, n. 6, p. e262, doi. 10.1111/hae.14036
- By:
- Publication type:
- Article
WFH Guidelines for the Management of Hemophilia, 3rd edition.
- Published in:
- Haemophilia, 2020, v. 26, n. 6, p. 1, doi. 10.1111/hae.14046
- By:
- Publication type:
- Article
World Federation of Hemophilia Gene Therapy Registry.
- Published in:
- Haemophilia, 2020, v. 26, n. 4, p. 563, doi. 10.1111/hae.14015
- By:
- Publication type:
- Article
Towards a global multidisciplinary consensus framework on haemophilia gene therapy: Report of the 2nd World Federation of Haemophilia Gene Therapy Round Table.
- Published in:
- Haemophilia, 2020, v. 26, n. 3, p. 443, doi. 10.1111/hae.13971
- By:
- Publication type:
- Article
Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study.
- Published in:
- Haemophilia, 2020, v. 26, n. 3, p. 494, doi. 10.1111/hae.13953
- By:
- Publication type:
- Article
Requirements to participate in haemophilia clinical trials.
- Published in:
- Haemophilia, 2020, v. 26, p. 22, doi. 10.1111/hae.13886
- By:
- Publication type:
- Article
Health‐related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non‐interventional study (NIS).
- Published in:
- Haemophilia, 2019, v. 25, n. 3, p. 382, doi. 10.1111/hae.13731
- By:
- Publication type:
- Article
Bleeding and safety outcomes in persons with haemophilia A without inhibitors: Results from a prospective non‐interventional study in a real‐world setting.
- Published in:
- Haemophilia, 2019, v. 25, n. 2, p. 213, doi. 10.1111/hae.13655
- By:
- Publication type:
- Article
The effect of emicizumab prophylaxis on health‐related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 Study.
- Published in:
- Haemophilia, 2019, v. 25, n. 1, p. 33, doi. 10.1111/hae.13618
- By:
- Publication type:
- Article
Bleeding events and safety outcomes in persons with haemophilia A with inhibitors: A prospective, multi‐centre, non‐interventional study.
- Published in:
- Haemophilia, 2018, v. 24, n. 6, p. 921, doi. 10.1111/hae.13612
- By:
- Publication type:
- Article
Once‐weekly prophylaxis with 40 IU/kg nonacog beta pegol (N9‐GP) achieves trough levels of >15% in patients with haemophilia B: Pooled data from the paradigm™ trials.
- Published in:
- Haemophilia, 2018, v. 24, n. 6, p. 911, doi. 10.1111/hae.13608
- By:
- Publication type:
- Article
Efficacy and safety of a VWF/ FVIII concentrate (wilate<sup>®</sup>) in inherited von Willebrand disease patients undergoing surgical procedures.
- Published in:
- Haemophilia, 2017, v. 23, n. 2, p. 264, doi. 10.1111/hae.13106
- By:
- Publication type:
- Article
Outcomes in children with hemophilia A with inhibitors: Results from a noninterventional study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Real-World Rates of Bleeding, Factor VIII Use, and Quality of Life in Individuals with Severe Haemophilia A Receiving Prophylaxis in a Prospective, Noninterventional Study.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 24, p. 5959, doi. 10.3390/jcm10245959
- By:
- Publication type:
- Article
PROFESSOR LIESL ZÜHLKE APPOINTED VICE PRESIDENT: EXTRAMURAL RESEARCH & INTERNAL PORTFOLIO.
- Published in:
- SA Heart Journal, 2022, v. 19, n. 2, p. 144
- By:
- Publication type:
- Article
Outcomes and management of invasive procedures in participants with hemophilia A post gene therapy: a post hoc analysis of the GENEr8-1 phase III trial.
- Published in:
- Therapeutic Advances in Hematology, 2024, v. 15, p. 1, doi. 10.1177/20406207241304645
- By:
- Publication type:
- Article
Updates in clinical trial data of extended half-life recombinant factor IX products for the treatment of haemophilia B.
- Published in:
- Therapeutic Advances in Hematology, 2018, v. 9, n. 11, p. 335, doi. 10.1177/2040620718802606
- By:
- Publication type:
- Article
BAY 81-8973, a full-length recombinant factor VIII for the treatment of hemophilia A: product review.
- Published in:
- Therapeutic Advances in Hematology, 2018, v. 9, n. 7, p. 191, doi. 10.1177/2040620718777903
- By:
- Publication type:
- Article
Point-of-care estimation of haemoglobin concentration in neonates and infants.
- Published in:
- South African Journal of Child Health, 2012, v. 6, n. 1, p. 10
- By:
- Publication type:
- Article
RNA sequencing suggests that non‐coding RNAs play a role in the development of acquired haemophilia.
- Published in:
- Journal of Cellular & Molecular Medicine, 2023, v. 27, n. 13, p. 1790, doi. 10.1111/jcmm.17741
- By:
- Publication type:
- Article
Long-acting recombinant factor IX Fc fusion protein ( rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG study.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 1, p. 124, doi. 10.1111/bjh.13112
- By:
- Publication type:
- Article
Hepcidin and GDF-15 are potential biomarkers of iron deficiency anaemia in chronic kidney disease patients in South Africa.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Hepatitis C virus genotypes in two different patient cohorts in Johannesburg, South Africa.
- Published in:
- Archives of Virology, 2008, v. 153, n. 11, p. 2049, doi. 10.1007/s00705-008-0227-2
- By:
- Publication type:
- Article
The genetic landscape of acute myeloid leukaemia in the South African public sector.
- Published in:
- South African Journal of Oncology, 2024, v. 8, p. 1, doi. 10.4102/sajo.v8i0.309
- By:
- Publication type:
- Article
Switching from Sucrose-Formulated rFVIII to Octocog Alfa (BAY 81-8973) Prophylaxis Improves Bleed Outcomes in the LEOPOLD Clinical Trials.
- Published in:
- Journal of Blood Medicine, 2023, v. 14, p. 379, doi. 10.2147/JBM.S405624
- By:
- Publication type:
- Article
AFFINITY.
- Published in:
- MD Conference Express, 2015, v. 15, n. 21, p. 9, doi. 10.1177/1559897715599367
- By:
- Publication type:
- Article
A cohort study of the relationship between anaemia, mean corpuscular volume and mortality among a CKD population in South Africa.
- Published in:
- African Health Sciences, 2021, v. 21, n. 4, p. 1764, doi. 10.4314/ahs.v21i4.33
- By:
- Publication type:
- Article
Long‐term safety and efficacy of the anti‐tissue factor pathway inhibitor marstacimab in participants with severe haemophilia: Phase II study results.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 2, p. 240, doi. 10.1111/bjh.18495
- By:
- Publication type:
- Article
A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 2, p. 229, doi. 10.1111/bjh.18420
- By:
- Publication type:
- Article
Non‐factor therapies for bleeding disorders: A primer for the general haematologist.
- Published in:
- EJHaem, 2022, v. 3, n. 3, p. 584, doi. 10.1002/jha2.442
- By:
- Publication type:
- Article
Bispecific Antibody Emicizumab for Haemophilia A: A Breakthrough for Patients with Inhibitors.
- Published in:
- BioDrugs, 2018, v. 32, n. 6, p. 561, doi. 10.1007/s40259-018-0315-0
- By:
- Publication type:
- Article
Ethnic prevalence of anemia and predictors of anemia among chronic kidney disease patients at a tertiary hospital in Johannesburg, South Africa.
- Published in:
- International Journal of Nephrology & Renovascular Disease, 2019, v. 12, p. 19, doi. 10.2147/IJNRD.S179802
- By:
- Publication type:
- Article